SCHEMBL9765041

SCHEMBL9765041

CCCCCCCN(CC1(c2ccccc2)CCCC1)C(=O)Nc1ccc(F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.55
SOAT2 O75908 1/20 0.54
ACAT1 P24752 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9765032 0.83 MMP1 (0.48) SOAT1
SCHEMBL6743943 0.81 SOAT1 (0.51) SOAT1SOAT2
SCHEMBL9765051 0.79 TP53 (0.43)
SCHEMBL10587594 0.79 SOAT1 (0.69) SOAT1SOAT2
SCHEMBL9263972 0.79 SOAT1 (0.69) SOAT1SOAT2
SCHEMBL6746999 0.78 SOAT1 (0.50) SOAT1
SCHEMBL9765055 0.78 SOAT1 (0.63) SOAT1SOAT2
SCHEMBL9152529 0.77 SOAT1 (0.67) SOAT1SOAT2
SCHEMBL9765049 0.77 SOAT2 (0.48) SOAT1SOAT2ACAT1
SCHEMBL9679689 0.77 RECQL (0.45) SOAT1SOAT2ACAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994465-A Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1991-02-19 US claimed
EP-0384320-A1 Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1990-08-29 EP claimed
US-4994465-A Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1991-02-19 US disclosed
EP-0384320-A1 Antihyperlipidemic and anti-atherosclerotic trisubstituted urea compounds WARNER-LAMBERT COMPANY (US) 1990-08-29 EP disclosed